LI drug firm set to brush up on sales
Long Island Business News
December 1, 2000
Frontier Pharmaceuticals hires Westbury Diagnostics to test DioxiBrite - a plaque and bacteria killing toothpaste. The active compound was screened against strep, staph, E. Coli, and yeast. Most toothpastes work by physically removing plaque, the sticky substance on teeth, made up of bits of food, in which the bacteria live. Frontier’s brand, DioxiBrite, actually kills them. Only Colgate-Palmolive has a similar product, Colgate Total, using the antibiotic Tryclosan. “We are better on plaque and just as good on gingivitis,” Frontier says. The findings were reported at the Annual Society for Microbiology.
Recent Posts
- We Are Your R&D Department
- Westbury Diagnostics, Inc. Participates in 2010 Long Island Works Job Fair
- FDA Guidance and Business Development Consulting Services
- Lorrence Green Named Director of Business Module for 2010 Fundamentals of the Bioscience Industry Program
- Lorrence Green Presents the “Anatomy of an Entrepreneur” at NYCBio
- Westbury Diagnostics Takes Equity Position in Pillar Rock USA Corp.
